Compounds > voriconazole
Page last updated: 2024-08-25

voriconazole and Genetic Predisposition

voriconazole has been researched along with Genetic Predisposition in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Sayegh, H; Bahrani, E; Bartenstein, D; Brahmbhatt, M; Chen, L; Coughlin, CC; Eichenfield, LF; Gerami, P; Haddock, E; Hawryluk, EB; Hook, K; Huang, JT; Humphrey, SR; Kruse, L; Lawley, L; London, WB; Mansour, D; Marghoob, A; Nguyen, J; Phung, TL; Pope, E; Raisanen, T; Robinson, S; Schmidt, B; Tran, G; Travis, K; Wolner, Z1
Arron, ST; Williams, K1
Balch, AH; Constance, JE; Enioutina, EY; Job, KM; Linakis, MW; Liu, X; Olson, J; Rower, JE; Sherwin, CM; Stockmann, C; Thorell, EA; Yu, T1
den Hollander, JG; Levin, MD; Rijnders, BJ; Sonneveld, P; van der Holt, B; van Schaik, RH; van Vliet, M1

Reviews

1 review(s) available for voriconazole and Genetic Predisposition

ArticleYear
Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections.
    Expert review of anti-infective therapy, 2016, Volume: 14, Issue:8

    Topics: Antifungal Agents; Area Under Curve; Dose-Response Relationship, Drug; Genetic Predisposition to Disease; Humans; Invasive Fungal Infections; Microbial Sensitivity Tests; Models, Biological; Voriconazole

2016

Other Studies

3 other study(ies) available for voriconazole and Genetic Predisposition

ArticleYear
Risk Factors and Outcomes of Nonmelanoma Skin Cancer in Children and Young Adults.
    The Journal of pediatrics, 2019, Volume: 211

    Topics: Adolescent; Antifungal Agents; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Case-Control Studies; Child; Child, Preschool; Female; Genetic Predisposition to Disease; Humans; Immunosuppressive Agents; Infant; Male; Radiotherapy; Retrospective Studies; Risk Factors; Skin Neoplasms; United States; Voriconazole; Young Adult

2019
Association of CYP2C19 *17/*17 Genotype With the Risk of Voriconazole-Associated Squamous Cell Carcinoma.
    JAMA dermatology, 2016, 06-01, Volume: 152, Issue:6

    Topics: Alleles; Antifungal Agents; Carcinoma, Squamous Cell; Cohort Studies; Cytochrome P-450 CYP2C19; Female; Genetic Predisposition to Disease; Genetic Variation; Genotype; Humans; Lung Transplantation; Male; Metabolic Clearance Rate; Postoperative Complications; Proportional Hazards Models; Risk; Skin Neoplasms; Voriconazole

2016
Hepatotoxicity of oral and intravenous voriconazole in relation to cytochrome P450 polymorphisms.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Female; Genetic Predisposition to Disease; Humans; Injections, Intravenous; Liver; Male; Middle Aged; Polymorphism, Genetic; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2007